Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
AstroNova
ALOT
$227M
| $1.78M | ﹤0.01% |
109,695
+2,232
| +2% | +$31K |
|
2027
iShares TIPS Bond ETF
TIP
$14.7B
| $1.78M | ﹤0.01% |
+16,600
| New | +$1.74M |
|
|
PSTX
2028
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.78M | ﹤0.01% |
530,100
-252,971
| -32% | -$652K |
|
2029
Knowles
KN
$3.29B
| $1.78M | ﹤0.01% |
99,200
-85,874
| -46% | -$1.33M |
|
2030
Personalis
PSNL
$1.5B
| $1.77M | ﹤0.01% |
840,811
+288,336
| +52% | +$373K |
|
2031
T. Rowe Price Capital Appreciation Equity ETF
TCAF
$8.32B
| $1.76M | ﹤0.01% |
+63,850
| New | +$1.65M |
|
2032
Xcel Energy
XEL
$49.5B
| $1.76M | ﹤0.01% |
28,500
-495,400
| -95% | -$29.7M |
|
2033
Curtiss-Wright
CW
$25.8B
| $1.76M | ﹤0.01% |
7,900
-12,800
| -62% | -$2.68M |
|
2034
MGE Energy Inc
MGEE
$3.09B
| $1.76M | ﹤0.01% |
24,339
+10,939
| +82% | +$792K |
|
2035
Seanergy Maritime Holdings
SHIP
$363M
| $1.76M | ﹤0.01% |
+224,500
| New | +$1.4M |
|
2036
CVRx
CVRX
$82.1M
| $1.76M | ﹤0.01% |
55,900
-9,800
| -15% | -$184K |
|
2037
Nerdy
NRDY
$90.4M
| $1.75M | ﹤0.01% |
511,600
-300
| -0.1% | -$920 |
|
2038
VirTra
VTSI
$36.5M
| $1.75M | ﹤0.01% |
185,300
+8,300
| +5% | +$54.1K |
|
2039
iShares MSCI Spain ETF
EWP
$2.22B
| $1.75M | ﹤0.01% |
+57,000
| New | +$1.64M |
|
2040
BayCom
BCML
$339M
| $1.74M | ﹤0.01% |
73,898
+18,898
| +34% | +$397K |
|
2041
SiriusPoint
SPNT
$2.76B
| $1.74M | ﹤0.01% |
150,100
-157,987
| -51% | -$1.67M |
|
|
BRDG
2042
DELISTED
Bridge Investment Group
BRDG
| $1.74M | ﹤0.01% |
177,581
+137,681
| +345% | +$1.12M |
|
|
ILPT
2043
Industrial Logistics Properties Trust
ILPT
$595M
| $1.74M | ﹤0.01% |
369,300
+244,300
| +195% | +$792K |
|
2044
Oric Pharmaceuticals
ORIC
$1.44B
| $1.73M | ﹤0.01% |
188,500
-191,300
| -50% | -$1.38M |
|
2045
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.28B
| $1.73M | ﹤0.01% |
81,500
+40,500
| +99% | +$820K |
|
2046
Hurco Companies Inc
HURC
$146M
| $1.73M | ﹤0.01% |
80,379
+7,697
| +11% | +$160K |
|
2047
Mirum Pharmaceuticals
MIRM
$6.14B
| $1.73M | ﹤0.01% |
58,648
-10,052
| -15% | -$304K |
|
2048
Design Therapeutics
DSGN
$928M
| $1.72M | ﹤0.01% |
648,800
+484,600
| +295% | +$1.11M |
|
|
SGMO
2049
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.71M | ﹤0.01% |
3,145,878
+780,124
| +33% | +$360K |
|
2050
Golar LNG
GLNG
$5.34B
| $1.71M | ﹤0.01% |
74,192
-302,012
| -80% | -$6.77M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.